Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy

Objectives. To evaluate the efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus (SLE) and lupus nephritis (LN) who are refractory to conventional immunosuppressive therapy. Methods. Eligible patients received rituximab at a dose of 1,000 mg at days 1, 15, 169, and...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mod Rheumatol
Main Authors: Tanaka, Yoshiya, Takeuchi, Tsutomu, Miyasaka, Nobuyuki, Sumida, Takayuki, Mimori, Tsuneyo, Koike, Takao, Endo, Kazuhiro, Mashino, Naomi, Yamamoto, Kazuhiko
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2016
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4732415/
https://ncbi.nlm.nih.gov/pubmed/26054418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/14397595.2015.1060665
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki